Faist Daphné, Gnesin Silvano, Medici Siria, Khan Alysée, Nicod Lalonde Marie, Schaefer Niklaus, Depeursinge Adrien, Conti Maurizio, Schaefferkoetter Joshua, Prior John O, Jreige Mario
Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 21, CH- 1011, Lausanne, Switzerland.
Institute of Radiation Physics, Lausanne University Hospital and University of Lausanne, Rue du Bugnon 21, CH- 1011, Lausanne, Switzerland.
Eur J Nucl Med Mol Imaging. 2025 Apr 25. doi: 10.1007/s00259-025-07259-2.
To assess feasibility of lung cancer screening, we analysed lung lesion detectability simulating low-dose and convolutional neural network (CNN) denoised [F]-FDG PET/CT reconstructions.
Retrospectively, we analysed lung lesions on full statistics and decimated [F]-FDG PET/CT. Reduced count PET data were emulated according to various percentage levels of total. Full and reduced statistics datasets were denoised using a CNN algorithm trained to recreate full statistics PET. Two readers assessed a detectability score from 3 to 0 for each lesion. The resulting detectability score and quantitative measurements were compared between full statistics and the different decimation levels (100%, 30%, 5%, 2%, 1%) with and without denoising.
We analysed 141 lung lesions from 49 patients across 588 reconstructions. The dichotomised lung lesion malignancy score was significantly different from 10% decimation without denoising (p < 0.029) and from 5% decimation with denoising (p < 0.001). Compared to full statistics, detectability score distribution differed significantly from 2% decimation without denoising (p < 0.001) and from 5% decimation with denoising (p < 0.001). Detectability scores at same decimation levels with or without denoising differed significantly at 10%, 2%, and 1% decimation (p < 0.019); dichotomised scores did not differ significantly. Denoising significantly increased the proportion of lung lesion scores with a high diagnostic confidence (3 and 0) (p < 0.038).
Lung lesion detectability was preserved down to 30% of injected activity without denoising and to 10% with denoising. These results support the feasibility of reduced-activity [F]-FDG PET/CT as a potential tool for lung lesion detection. Further studies are warranted to compare this approach with low-dose CT in screening settings.
为评估肺癌筛查的可行性,我们分析了模拟低剂量和卷积神经网络(CNN)去噪后的[F]-FDG PET/CT重建图像中肺部病变的可检测性。
我们回顾性分析了全统计量和抽取后的[F]-FDG PET/CT上的肺部病变。根据总量的不同百分比水平模拟减少计数的PET数据。使用经过训练以重建全统计量PET的CNN算法对全统计量和减少统计量的数据集进行去噪。两名阅片者对每个病变的可检测性评分从3到0进行评估。比较了全统计量与不同抽取水平(100%、30%、5%、2%、1%)在有无去噪情况下的最终可检测性评分和定量测量结果。
我们分析了来自49例患者的141个肺部病变,共588次重建图像。二分法的肺部病变恶性评分与未去噪的10%抽取水平(p < 0.029)以及去噪的5%抽取水平(p < 0.001)有显著差异。与全统计量相比,可检测性评分分布与未去噪的2%抽取水平(p < 0.001)以及去噪的5%抽取水平(p < 0.001)有显著差异。在10%、2%和1%抽取水平下,有无去噪时相同抽取水平的可检测性评分有显著差异(p < 0.019);二分法评分无显著差异。去噪显著提高了具有高诊断置信度(3和0)的肺部病变评分比例(p < 0.038)。
在未去噪的情况下,肺部病变可检测性在注射活度降至30%时仍能保持,去噪时降至10%时仍能保持。这些结果支持了低活度[F]-FDG PET/CT作为肺部病变检测潜在工具的可行性。有必要进行进一步研究,以在筛查环境中将这种方法与低剂量CT进行比较。